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ABSTRACT: Disturbances in lung function and lung mechanics are present after ven-
tilation with high peak inspiratory pressures (PIP) and low levels of positive end-
expiratory pressure (PEEP). Therefore, the authors investigated whether partial liquid
ventilation can re-establish lung function after ventilation-induced lung injury.
Adult rats were exposed to high PIP without PEEP for 20 min. Thereafter, the ani-
mals were randomly divided into five groups. The first group was killed immediately
after randomization and used as an untreated control. The second group received only
sham treatment and ventilation, and three groups received treatment with perfluoro-
carbon (10 mL?kg-1, 20 mL?kg-1, and 20 ml?kg-1 plus an additional 5 mL?kg-1 after 1 h).
The four groups were maintained on mechanical ventilation for a further 2-h observation
period. Blood gases, lung mechanics, total protein concentration, minimal surface ten-
sion, and small/large surfactant aggregates ratio were determined.
The results show that in ventilation-induced lung injury, partial liquid ventilation with
different amounts of perflubron improves gas exchange and pulmonary function, when
compared to a group of animals treated with standard respiratory care. These effects
have been observed despite the presence of a high intra-alveolar protein concentration,
especially in those groups treated with 10 and 20 mL of perflubron.
The data suggest that replacement of perfluorocarbon, lost over time, is crucial to
maintain the constant effects of partial liquid ventilation.
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It is known that modes of mechanical ventilation
which allow end-expiratory alveolar collapse and/or
end-inspiratory alveolar overstretching result in a
decrease of lung compliance and gas exchange, and
lead to atelectasis, pulmonary oedema, pneumonitis
and fibrosis: for review see [1]. Development of intra-
alveolar protein-rich oedema in healthy rats subjected
to intermittent positive pressure ventilation at high
inflation pressures, without positive end-expiratory
pressure (PEEP), was first demonstrated by WEBB and
TIERNEY [2] and was later confirmed by DREYFUSS
and coworkers [3, 4] who suggested that high ins-
piratory lung volumes induce endothelial and epithe-
lial overstretching leading to microvascular injury.
Additionally, it is known that large changes in both
volume and surface area result in surfactant depletion
from the alveoli into the airways as well as to trans-
formation from surface active large aggregates to
inactive small aggregates [5 – 9]. Thus, loss of surfac-
tant function will increase the surface tension at the
air-liquid interface of the alveolar walls resulting in
alveolar collapse and an increased suction force on the
pulmonary interstitium which causes more alveolar
oedema. The epithelial/endothelial damage results
mainly from the shear forces which appear in a
nonhomogeneous ventilated lung [4, 8].
It is known that perfluorocarbons (PFCs) have a
surfactant-like activity due to their low surface ten-
sion (18 mN?m-1), which in a surfactant-deficient lung
decreases the high surface tension at the air-liquid
interface [10 – 13]. Based on this low surface tension,
the resulting peak inspiratory pressure (PIP) during
volume-controlled ventilation are reduced [10, 11, 13].
Another property of PFCs is their high density which,
mainly in the dependent part of the lung, recruits
collapsed alveolar units [14, 15]; the combination of
PFCs with gas ventilation, better known as partial
liquid ventilation (PLV), also improves gas exchange
in surfactant-deficient lungs [10, 11]. Additionally,
because PFCs might not be affected by the presence of
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plasma proteins in the alveolus, PFC might prove
useful as a treatment for ventilation-induced injury
[16, 17]. Therefore, the aim of this study was to
establish whether PLV can re-establish lung function
in ventilation-induced lung injury (VILI).
Material and methods
Animal preparation
This study was approved by the local Animal
Committee at the Erasmus University Rotterdam. The
study was performed in 30 adult male Sprague-
Dawley rats (body weight 280 – 350 g). After induct-
ion of anaesthesia with 2% enflurane and 65% nitrous
oxide in oxygen, a polyethylene catheter was inserted
into a carotid artery for drawing arterial blood
samples and continuous monitoring of arterial blood
pressure. Before tracheotomy, the animals received
30 mL?kg-1 pentobarbital sodium, intraperitoneal (i.p.)
(Nembutal1, Algin BV, Maassluis, the Netherlands).
After tracheotomy, muscle relaxation was induced by
pancuronium bromide 0.6 mL?kg-1, intramuscular
(i.m.) (Pavulon1, Organon Teknika, Boxtel, the
Netherlands) immediately followed by connection to
a ventilator and a pressure transducer for continuous
monitoring of arterial blood pressure. The animals
were mechanically ventilated with a Servo Ventilator
300 (Siemens-Elema, Solna, Sweden) in a pressure
constant time-cycled mode, at an inspired oxygen
concentration (FI,O2) of 1.0, frequency of 30 breaths
per minute (bpm), PIP of 12 cmH2O, PEEP of
2 cmH2O, and inspiratory:expiratory (I:E) ratio of
1:2. Anaesthesia was maintained with pentobarbital
sodium 30 mL?kg?h-1, i.p.; muscle relaxation was
maintained with pancuronium bromide 0.6 mL?kg?h-1
i.m. Body temperature was kept within the normal
range by means of a heating pad.
Experimental design
To produce ventilation VILI, PIP was increased to
45 cmH2O and PEEP was decreased to zero for
20 min, whereas the other ventilator settings were not
changed. Thereafter, a 5-min period of hypoventila-
tion was introduced (i.e. PIP decreased to 26 cmH2O
and PEEP increased to 6 cmH2O) to increase arterial
carbon dioxide (CO2). These ventilator settings were
chosen based on a pilot study (unpublished data)
which showed that animals ventilated at 45/0 cmH2O
(PIP/PEEP, respectively) for 20 min and then venti-
lated at 30/10 cmH2O died from severe hypocapnia.
Experimental groups
The animals were randomized to one of five groups
(n~6 per group). In the first group (untreated
controls), the animals were killed after the 5-min
ventilation period of 26/6 (PIP/PEEP) with an over-
dose of pentobarbital. In each animal the thorax and
diaphragm were opened, the tracheotomy catheter
was connected to a pressure transducer and a
pressure/volume curve (P/V curve) was immediately
recorded (see later); thereafter a bronchoalveolar
lavage (BAL) was performed five times with saline-
CaCl2 (see later). This group was used as an untreated
control group. The second group (sham-treated
controls) received a sham bolus of air 28 mL?kg-1
intratracheally and was mechanically ventilated at a
PIP of 30 cmH2O, PEEP of 10 cmH2O, I:E ratio of
1:2, FIO2 1.0, and respiratory rate of 40 bpm for 2 h.
These ventilator settings were chosen based on a
preliminary study which showed that pressures of
26/6 cmH2O (PIP/PEEP, respectively) and 28/8 cmH2O
were too low to keep animals alive for a 2-h obser-
vation period. Three groups received PFC at a dose
of 10 mL?kg-1 (PFC10), 20 mL?kg-1 (PFC20), or
20 mL?kg-1 plus after 60 min, an extra dose of
5 mL?kg-1 (PFC20zR); this extra dose was based on
a previous experience with this model (unpublished
data) and aimed to maintain oxygen tension in art-
erial blood (Pa,O2) as stable as possible during the
remainder of the study period.
Treatment with perfluorocarbons
The PFC used in this study (Liquivent1, Alliance
Pharmaceutical, San Diego, CA, USA) is insoluble in
water, has a specific gravity of 1.918 g?cm-1 at 25uC, a
surface tension of 18.1 dynes?cm-1, vapour pressure of
3.6 torr (0.5 kPa) at 20uC and 10.5 torr (1.4 kPa) at
37uC, an oxygen solubility of 53 mL?100 mL-1 and
CO2 solubility of 210 mL?100 mL
-1 at 37uC, at 1
atmosphere pressure [10, 11]. The groups PFC10 and
PFC20 received a single dose of PFC intratracheally.
The PFC20zR group received an initial dose of
20 mL?kg-1 of PFC and, after 60 min, an extra dose
of 5 mL?kg-1 of PFC was instilled intratracheally to
compensate loss of PFC due to evaporation. At instil-
lation, animals were disconnected from the ventilator
and PFC was administered directly into the endo-
tracheal tube over 3 – 5 s; the animals were then
immediately reconnected to the ventilator.
Gas exchange and haemodynamics
Arterial blood gas samples were taken in all groups
before, after VILI, and at 5 min after the 26/6 period,
and in the four ventilated groups at 5 min after the 30/
10 period, and at 30, 60, 90 and 120 min after PFC
instillation. The samples were analysed for Pa,O2 and
arterial carbon dioxide tension (Pa,CO2) by convent-
ional methods (ABL 505, Radiometer, Copenhagen,
Denmark). At the same time points, arterial press-
ure was recorded. Haemodynamic support was pro-
vided by infusion of 1 mL of saline (to a maximum
of 2 mL?h-1) when mean arterial pressure (MAP)
decreased v60 mmHg.
Pressure/volume curves
At 120 min after administration of PFC all animals
were killed with an overdose of pentobarbital sodium
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injected through the penile vein. Then static P/V
curves were recorded. After the thorax and diaph-
ragm were opened (to eliminate the influence of chest
wall compliance and intra-abdominal pressure), the
tracheotomy catheter was connected to a pressure
transducer (Validyne model DP 45-32, Validyne
Engineering Co., Northridge, CA, USA) with a
syringe attached to it, and pressures were recorded
on a polygraph (Grass model 7B, Grass Instrument
Co., Quincy, MA, USA). Using a syringe filled with
nitrogen the lungs were first inflated (within 10 s) to
an airway pressure of 35 cmH2O, which was main-
tained for 5 s, followed by deflation to an airway
pressure of 0 cmH2O. Then the lungs were re-inflated
in steps of 0.5 mL until an airway pressure of
35 cmH2O was reached. Each inflation step took
1 – 2 s followed by a 5-s pause to allow pressure
equilibration. After this, in the same way, the lungs
were then deflated until an airway pressure of
0 cmH2O was reached. The volume of nitrogen left
in the syringe was recorded. The lower inflection point
(LIP) was determined from the intersection of the
lines representing the minimum slope of the compli-
ance curve and the maximum slope of the compliance
curve. Maximal compliance (Cmax) was calculated
from the steepest part of the deflation limb [18]. Total
lung capacity (TLC35) was defined as lung volume at
inflation with a distending pressure of 35 cmH2O [19].
Gruenwald index
The Gruenwald index which characterizes the
surfactant system in situ [20], was calculated from
the P/V curve, defined as (2V5zV10)/2Vmax, where V5,
V10 and Vmax are the lung volumes at airway pressures
of 5, 10 and 35 cmH2O from the deflation limb,
respectively.
Bronchoalveolar lavage
After the P/V curve recordings a BAL (30 mL?kg-1)
was performed five times with saline-CaC12
1.5 mmol?L-1. In the resultant BAL (crude lavage)
there were two visible layers, the upper layer was
composed of the saline-CaCl2, oedema fluid and cell
debris, and the bottom layer comprised only PFC.
Thereafter, cell debris and PFC were removed from
BAL by centrifugation at 4006g for 10 min. The
active surfactant component in the BAL fluid was
separated from the nonactive surfactant component
by differential centrifugation, followed by phosphorus
analysis, and the ratio of nonactive to active (small to
large aggregate) surfactant was calculated [21].
Finally, the protein concentration of the BAL fluid
was determined using the Bradford method (Bio-Rad
protein-assay, Munich, Germany) [22].
Minimal surface tension
Minimal surface tension of the crude lavage was
determined by means of a modified Wilhelmy balance
(E. Biegler GmbH, Mauerbach, Austria). In this
method, a tight-fitting teflon barrier reduces the
surface area of a teflon trough from 100 – 20% at a
cycle speed of 0.33 min-1. Saline is used as subphase
and is kept at 37uC. The force on a platinum slide
(161 cm) is measured by a force transducer and
expressed as surface tension. Further, maximal surface
tension is measured at 100% surface area and minimal
surface tension at 80% surface compression and
expressed as milli Newton?metre-1 (mN?m-1). Surface
tension characteristics of a BAL sample are measured
after application on the surface of the saline-filled
trough. In this study 300 mL of BAL fluid was applied
to the surface of the trough; surface tension was
measured after 3 cycles [23].
Statistical analysis
Statistical analysis was performed using the Instat
2.0 biostatistics package (GraphPad software, San
Diego, CA, USA). Intragroup comparisons were
analysed with repeated measures using analysis of
variance (ANOVA); intergroup comparisons were
analysed with ANOVA. If a difference was found, a
post hoc test was performed (Tukey-Kramer). Statis-
tical significance was accepted at p-values v0.05. All
data are expressed as mean¡standard deviation.
Results
Figure 1 shows the Pa,O2 levels during the whole
study period. After VILI and the ventilator settings
were set at 26/6 cmH2O for 5 min the Pa,O2 decreased
v13.3 kPa in all groups. After PFC instillation and
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Fig. 1. – Arterial oxygen tension (mean¡SD) during the whole
study period. B: baseline; VILI: ventilation with peak inspiratory
pressure (PIP) of 45 cmH2O without peak end-expiratory pressure
(PEEP) after 20 min; 26/6: after 5 min at PIP 26 cmH2O PEEP;
arterial carbon dioxide tension (Pa,O2) at 60 min in the group
PFC20zR was measured before instillation of the additional 5 mL
perflubron dose; PFC: perfluorobcarbons. PFC10: PFC at dose of
10 mg?kg-1; PFC20: PFC at dose of 20 mg?kg-1; PFC20zR: PFC at
dose of 20 mg?kg-1 plus 5 mg?kg-1 after 60 min of ventilation. h:
untreated; &: sham-treated; E: PFC10: &: PFC29; u: PFC20zR.
*: significant difference with sham-treated control group; z: signifi-
cant difference with PFC10, #: significant difference with PFC20.
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after increasing the pressures to 30/10 cmH2O the
PFC20 and PFC20zR groups showed a significant
increase in Pa,O2 values to pre-VILI levels (pv0.001),
but only the PFC20zR group maintained oxygen
tension levelsw60 kPa during the 2-h study period. In
both groups with a single dose of PFC (PFC10 and
PFC20) Pa,O2 values decreased over time. There were
significant differences between the values in the
ventilated and PFC10 groups compared with the
values of the PFC20zR throughout the study period
(pv0.001).
Table 1 shows that the Pa,CO2 values and MAP
levels were comparable in all groups during the whole
study period.
Table 2 shows data from BAL fluid and lung
mechanics. Protein concentration was significantly
higher in the PFC10 group compared with the
untreated and the PFC20zR groups. The Gruenwald
Index and the minimal surface tension of the crude
lavage fluid from all ventilated groups were not
significantly different from the untreated control
group. For data on TLC35, Cmax, and LIP see
table 2 and figures 2a and b. The total phosphorous
concentration in the BAL fluid was not different
between groups. The ratio of small to large aggregates
in BAL fluid was significantly higher in the four
ventilated groups compared with the untreated con-
trol group, and there was no significant difference
between the sham-treated control group and all the
PFC-treated groups.
Figure 2a shows the inflation limbs from the P/V
curves. Both PFC groups treated with 20 mL?kg-1
have a significantly lower opening pressure than both
the untreated and the sham-treated control groups.
The PFC20zR group had a significantly higher TLC35
than both the untreated and sham-treated control
groups. Figure 2b shows the deflation limbs from the
P/V curves. The three PFC-treated groups had a
Table 1. – Data on arterial carbon dioxide tension (Pa,CO2) and mean arterial pressure (MAP) over time in both the treated
and untreated groups
Time min Untreated Sham-Treated PFC10 PFC20 PFC20zR
Pa,CO2 kPa Baseline 4.7¡0.7 5.3¡1.6 4.8¡0.97 4.9¡0.8 5.6¡1.7
VILI 2.5¡0.3 2.4¡0.6 2.5¡0.35 2.7¡0.4 2.9¡0.5
5 26/6 4.7¡0.7 5.3¡1.0 5.0¡2.1 5.2¡0.89 6.7¡1.7
5 30/10 5.3¡1.3 4.3¡0.4 4.8¡0.7 5.7¡0.8
30 5.6¡1.3 3.9¡0.4 4.4¡0.9 5.4¡0.9
60 6.3¡1.6 4.4¡1.3 4.4¡0.7 4.7¡1
90 6.5¡1.3 4.8¡1.2 4.7¡0.5 5.6¡0.8
120 6.9¡1.8 4.8¡2.1 4.9¡0.3 4.4¡0.9
MAP mmHg Baseline 135¡16 134¡15 144¡6 140¡24 136¡17
VILI 75¡25 84¡32 72¡25 85¡22 71¡21
5 26/6 74¡30 63¡42 47¡24 67¡36 89¡32
5 30/10 111¡12 88¡24 106¡25 97¡14
30 91¡24 80¡20 89¡21 90¡9
60 89¡19 78¡17 95¡15 95¡37
90 86¡29 76¡17 97¡15 97¡12
120 89¡27 85¡9 73¡24 80¡13
Data are presented as mean¡SD. Untreated: nonventilated control. Sham-treated is the Sham-treated, ventilated control;
PFC10: partial liquid ventilation (PLV) with perfluorocarbons (PFC) at dose 10 mg?kg-1; PFC20: PLV with PFC at dose
20 mg?kg-1; PFC20zR: PLV with PFC at dose 20 mg?kg-1 plus 5 mg?kg-1 after 60 min of ventilation; VILI: ventilation
induced lung injury; Baseline: measurement before VILI.
Table 2. – Amount of recovered bronchoalveolar ravage (BAL) fluid, protein concentration, lung volume above functional
residual capacity at pressure 35 cmH2O (TLC35), maximum compliance (Cmax), Gruenwald Index, lower inflection point of
the pressure volume curve (LIP), minimal surface tension (min surf) of crude BAL fluid, total phosphorus concentration,
and small aggregates (SA)/large aggregates (LA) ratio
Untreated Sham-Treated PFC10 PFC20 PFC20zR
Recovery BAL fluid % 90¡1 90¡1 90¡1 90¡1 90¡1
Protein concentration BAL mg?mL-1 1.3¡0.3* 1.4¡0.4 1.9¡0.2 1.8¡0.3 1.4¡0.1*
TLC35 35¡2** 31¡3*,z,** 38¡4 39¡4 42¡5
Cmax mL?kg-1 1.5¡0.3*,z,** 1.4¡0.2*,z,** 2.4¡0.2 2.6¡0.2 2.8¡0.6
Gruenwald index 0.30¡0.09 0.40¡0.17 0.40¡0.07 0.4¡0.07 0.5¡0.2
LIP cmH2O 15.3¡1.4*
,z,** 18.2¡2*,z,** 10.8¡1.2** 10.6¡3.3** 6.7¡1.9*
Min surf mN?m-1 33¡3.1 31¡1.6 35¡2.1 35¡0.5 32¡3.9
Total phosphorus mmol 2.0¡0.6 1.4¡0.5 1.7¡0.4 1.5¡0.3 1.5¡0.2
SA/LA ratio 1.7¡1.1*,z,** 4.6¡2.7 4.6¡2.3 5.6¡3.5 4.2¡2.7
Values are presented as mean¡SD. Untreated: nontreated, nonventilated control group; Sham-treated: Sham-treated,
ventilated control group; PFC10: PFC 10 mg?kg-1; PFC20: PFC 20 mg?kg-1; PFC20zR: PFC 20 mg?kg-1z5 mg?kg-1 after
60 min of ventilation to replace PFC loss due to evaporation; PFC: perfluorobcarbons. *: versus PFC10, pv0.05; z: versus
PFC20, pv0.05; **: versus PFC20zR, pv0.05.
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significantly higher Cmax than both untreated and the
sham-treated control groups.
Discussion
This study shows that partial liquid ventilation
improves Pa,O2 and lung mechanics in a model of
ventilation-induced lung injury, despite the presence
of a high intra-alveolar protein concentration. The
authors have previously shown that this model of
VILI is characterized by a decrease in lung mechanics
and Gruenwald Index, and a high minimal surface
tension in BAL fluid compared with healthy rat lungs
[8]. The exact mechanism by which the lung damage is
produced by artificial ventilation is not entirely clear,
but the role of surfactant changes is being stressed [8,
9, 16]. The present group have shown that modes of
ventilation with large tidal volume without PEEP
disturb the surfactant system in a VILI model [8]. It
has been demonstrated that loss of surface active
molecules due to mechanical ventilation with high
inspiratory lung volumes without PEEP is produced
by displacement of surfactant from the alveolar air-
liquid interface into the small airways [2, 5]. More-
over, the surface area changes produced by the high
inspiratory lung volumes lead to an increased rate of
conversion of active into nonactive surfactant sub-
tractions [7 – 9]. All these mechanisms will lead to
alveolar collapse and protein infiltration [2 – 4, 8, 9] in
which the latter leads to further inactivation of
surfactant [24, 25]. In the current study PLV was
used to improve the disturbed lung function caused by
VILI. The results showed that after VILI, PLV
produced an immediate dose and time-dependent
improvement in Pa,O2. In the group treated with
10 mL?kg-1 PFC the pre-VILI values of Pa,O2 were
never reached, whereas in both groups treated with
20 mL?kg-1 PFC, within 5 min there was a significant
increase in Pa,O2 values compared with values after
VILI, and these improved values were comparable
with baseline values. However, Pa,O2 decreased over
time in both groups in which PFC was not replaced. It
has been shown that in surfactant-deficient animal
lungs PLV provides adequate gas exchange as long as
a sufficient amount of PFC is present in the lungs
[10 – 13]. The present group has demonstrated that
higher doses of PFC lead to higher levels of
oxygenation in animals suffering from acute respira-
tory failure as a result of dose-dependent recruitment
of collapsed atelectatic alveoli by PFC [10, 11]. It is
also known that oxygenation deteriorates over time if
no additional doses of PFC are instilled; this is
attributed to evaporation of PFC which will cause
affected alveoli to collapse [10, 11].
In the present study, the inflation limbs of the P/V
curves showed on the one hand, a significantly lower
opening pressure in the three PFC-treated groups and,
on the other, a significantly higher maximal compli-
ance compared with both control groups. It may be
speculated that one of the reasons for this is that in the
surfactant-deficient lungs, the decrease of surface
tension at the air-liquid interface by PFC (vapour)
improves the mechanical properties of the lung [10,
11, 26 – 29]. These findings have previously been
demonstrated by KIRMSE et al. [14] showing that
with increasing amounts of perflubron the LIP de-
creases to a point where additional doses of perflu-
bron have no further influence on the detectable LIP.
A side-effect of PFC may be the constant surface
tension which does not change with the changes in
surface area (which is a property of natural surfac-
tant) so that the end-expiratory stability in the PFC-
treated animals (characterized by the Gruenwald
Index) was not statistically different from the sham-
treated control animals [13].
In the current study, the protein level from the
crude BAL fluid in all ventilated groups was as high as
in the untreated ventilated control group. Moreover,
in both PFC-treated groups without replacement, an
increase in the total protein concentration was
observed. Additionally, the data show that with a
larger amount of PFC (PFC20zR) in the lung, the
total amount of protein in the BAL fluid is less. How
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Fig. 2. – a) Inflation limbs from the pressure/volume curves
(mean¡SD). Untreated: untreated, nonventilated control group.
Lower inflection point. b) Deflation limbs from the pressure/volume
curves (mean¡SD). PFC10: PFC at dose of 10 mg?kg-1PFC20:
PFC dose of 20 mg?kg-1; PFC20zR: PFC dose at 20 mg?kg-1 plus
5 mg?kg-1 ventilation after 60 min of ventilation. $: untreated;
,: sham-treated; h: PFC10; ': PFC20; ): PFC20zR. *: signifi-
cant differences between PFC20zR versus untreated; **: significant
differences between PFC20zR versus sham-treated; z: significant
differences between PFC20 versus sham-treated; #: PFC10 versus
untreated; }: significant difference between PFC10 versus sham-
treated; §: significant difference between PFC20 versus untreated.
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PFC prevents protein infiltration and alveolar flood-
ing is not entirely clear. DREYFUSS et al. [26] showed in
rats that PFC partially reversed the effects of alveolar
flooding (the so-called tamponade effect), but in some
rats, did not reduce the permeability changes on the
alveolo-capillary membrane measured by 125I-labelled
serum albumin. It has been suggested that as a result
of the PFC-filled alveoli, the suction forces on the
interstitium more or less disappear thus preventing
protein influx into the PFC-filled alveoli. However,
alveoli which have only a PFC film at the air-liquid
interface and which may collapse during expiration
will promote alveolar flooding due to their high
surface tension at end-expiration; this could be one
reason why the amount of proteins in the PFC group
receiving only 10 mL?kg-1 PFC is significantly higher
than in the PFC20zR group.
In conclusion, the results of the present animal
study show that in ventilator-induced lung injury,
partial liquid ventilation with different amounts of
perflubron improves gas exchange and pulmonary
function, when compared to a group of animals
treated with standard respiratory care. These effects
have been observed despite the presence of a high
intra-alveolar protein concentration, especially in
those groups treated with 10 and 20 mL of perflubron.
The data suggest that replacement of perfluorocarbon
lost over time is crucial to maintain constant effects of
partial liquid ventilation.
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